Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Presentation of Intrum’s results for April-June 2021

Intrum announces its interim results for April-June 2021 on 22 July, 2021 at 7:00 a.m. CET. The report will be presented in a audio cast with telephone conference at 9:00 a.m. CET the same day.Anders Engdahl, President & CEO, and Michael Ladurner, CFO, will present the results and answer questions. The conference will be held in English. To listen in to the conference live, please dial: +46 8 505 583 73 (SE)+44 33 3300 9266 (UK)+1 646 722 4904 (US) Link to live audio cast   The link to the live audio cast is also available on www.

Bambuser Partners with Digital Agency oddity to Elevate Live Video Shopping Across the DACH Region

[Joint image of CEO Bambuser and Managing Director oddity] Stockholm - 1 July 2021 - Bambuser and oddity group , the German-based creative and digital marketing agency, today announced a partnership that will bring Live Video Shopping to more brands and retailers in the DACH region. The partnership will combine the technical expertise of Bambuser, recent winner of the LVMH Innovation Award, with oddity’s deep insights into strategies for driving success across the entire customer journey. The teams within the oddity group that specialize in consumer and channel

Cantargia advances development of nadunolimab in triple negative breast cancer through submission of clinical protocol for TRIFOUR study

Cantargia AB today announced the submission of the clinical trial application for TRIFOUR, a phase Ib/II trial investigating nadunolimab (CAN04) combined with gemcitabine and carboplatin for treatment of triple negative breast cancer (TNBC). After an initial safety lead in, the study will include a randomized phase II part. This trial will be performed in Spain in collaboration with the Spanish Breast Cancer Group, GEICAM. Up to 120 patients may be included and the first patient is estimated to be enrolled in November 2021.The antibody CAN04, binding to interleukin-1 receptor accessory

Volvo Penta starts production of E-driveline for world’s first serial electric fire truck

Volvo Penta has commenced production of bespoke electric drivelines for leading fire service vehicle manufacturer Rosenbauer’s pioneering fire truck, named “Revolutionary Technology” (RT).“We announced our emob partnership with Rosenbauer  in 2019, and we have gone from concept to start of production in record time,” says Giorgio Paris, President of Volvo Penta Industrial. “This is a milestone in our electrification journey. We see a growing demand for electric solutions in the market today

SaltX in cooperation agreement with ABB

- Strengthens the technical platform with system for automation and control Nasdaq First North-listed SaltX Technology has signed a letter of intent with ABB regarding cooperation in systems for automation and control processes to strengthen SaltX's technical platform of EnerStore.The companies will jointly ensure a stable and scalable control system to strengthen SaltX's technical platform. ABB has a long and solid experience in complex control systems and will be able to contribute to optimizing and securing the automation and control system in both the short and long term for the

New CEO in Centiglobe - Centiglobe has appointed Petter Sandgren as new CEO. Petter will succeed Henrik Gradin who takes on the role as Chief Strategy Officer.

Centiglobe Technologies is an innovative fintech company offering a blockchain based platform enabling cross-border payments in real-time.Henrik Gradin - I am proud of how Centiglobe has evolved and been able to create a cutting edge blockchain technology that enables international payments in real time. We now take the next step in commercialization and it is a good time for new leadership. This gives me the opportunity to spend more time with strategy and business development to further develop the Centiglobe platform and to ensure Centiglobe stays in the forefront. Petter has

BioStock: First impressions from Alligator’s new CEO

In June 2021, Søren Bregenholt began his new role as CEO for Lund-based company Alligator Bioscience. The company is about to initiate a phase II trial with mitazalimab, and drug candidate ATOR-1017 is soon to follow. Other projects are also advancing, and BioStock had the opportunity to talk to Bregenholt about his first impressions and what he expects to achieve as CEO of Alligator.Read the full interview with Alligator Bioscience's CEO Søren Bregenholt at biostock.se: https://www.biostock.se/2021/07/first-impressions-from-alligators-new-ceo/ This is a press release from BioStock -

2cureX and University Hospital of Hamburg-Eppendorf present IndiTreat data at ESMO GI for early-stage Pancreatic Cancer

2cureX announces the presentation of the poster [P-288] “Individual Drug Screening and heterogeneity analysis of patient derived tumoroids – Roadmap to improving therapy in Pancreatic Cancer” at the 2021 ESMO World Congress on Gastrointestinal Cancer (ESMO GI) starting yesterday. The poster is presented jointly with the University Hospital of Hamburg - Eppendorf (UKE - Hamburg, Germany) as part of a collaboration to bring Functional Testing to Pancreatic Cancer.The poster confirms the feasibility of using Functional Testing on resected tissue samples coming from the primary tumor, opening

BioStock: 2021 represents beginning of new era for Fluicell

As we head into the summer, BioStock takes a look at Fluicell’s achievements so far this year. Standing out are the company’s launch of their latest product, Biozone 6, and its dive into the regenerative medicine field through its BioRej Advance programme. BioStock spoke with Fluicell’s CEO Victoire Viannay to get her thoughts on the company’s new direction and what milestones Fluicell has its sights on for the rest of 2021.Read the interview with Victoire Viannay at biostock.se: https://www.biostock.se/en/2021-represents-beginning-of-new-era-for-fluicell/ This is a press release from

Carbiotix evaluation of new production enzyme yields positive results

Carbiotix (publ) ("Carbiotix" or “the Company”) today announces that it has completed a comprehensive evaluation of a new production enzyme supplied by a potential strategic partner yielding positive results. The Company will now proceed with the GRAS Self Affirmation process.Carbiotix communicated at the end of Q1 2021 that it would undertake a comprehensive evaluation of a new production enzyme supplied by a leading global enzyme producer and potential strategic partner in Q2 2021. This enzyme had the potential to accelerate achieving FDA GRAS No Objection and EFSA Novel Foods status in

Today Australian hygiene company Asaleo Care becomes Essity

Hygiene and health company Essity has today finalized its acquisition of the remaining 63.8% of the shares in the Australian hygiene company Asaleo Care. Essity AustralAsia, which is the name of the regional unit going forward, will be consolidated into Essity’s accounts as of July 1[st ], 2021.“It is with great pleasure we today welcome our new colleagues in Australia, New Zealand and the Pacific Islands to Essity. Together we will continue to improve well-being through our leading products and solutions and facilitate the opportunity for profitable growth in this region”, says Magnus

Beijer Ref becomes the majority owner of Fenagy A/S

Beijer Ref has entered into an agreement to increase its holding in the Danish refrigeration technology company Fenagy A/S. With an investment of DKK 19 million, Beijer Ref expands its ownership to just over 50 percent and thus becomes the majority shareholder. The company will be included in the financial accounts as of July 1, 2021, and will have a minor impact on the company’s earnings and position. The investment gives Fenagy the financial conditions necessary to strengthen the organization and meet the needs of the market. Beijer Ref made its first investment in Fenagy in

Will Martin Assumes Role as President and Chief Executive Officer of IRRAS

Stockholm, July 1, 2021 - IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that Will Martin has formally assumed the role of President and Chief Executive Officer (CEO), which comes as part of a planned succession process first announced in April 2021. Kleanthis G. Xanthopoulos, Ph.D., will step down as CEO and will remain on the Company’s Board of Directors. Will Martin joined IRRAS as Chief Commercial Officer in 2018. Prior to IRRAS, he most recently served as General Manager of the

Change in Konecranes Leadership Team

KONECRANES PLC STOCK EXCHANGE RELEASE July 1, 2021 at 9:30 EEST Change in Konecranes Leadership Team Timo Leskinen, SVP for Human Resources and a member of the Konecranes Leadership Team, has decided to leave the company and will take a position at another company. He will leave Konecranes on 30 September 2021. “Timo has been a highly valued member of our Konecranes Leadership Team during the past eight years. I want to thank Timo for all his contributions at Konecranes and wish him the best of luck in his future career”, says Rob Smith, President and CEO of Konecranes.

NALCO selects Metso Outotec to deliver bauxite grinding package to their Damanjodi Alumina Refinery

Metso Outotec Corporation’s press release on July 1, 2021, at 09:30 a.m. EESTMetso Outotec has been awarded a contract for the engineering and delivery of a bauxite grinding package to National Aluminium Company’s (NALCO) Damanjodi Alumina Refinery for their 5[th] stream expansion project in Odisha, India. Typically, the value of this type of an order is in the range of EUR 12-15 million. The order has been booked in Minerals’ Q2/2021 orders received.Metso Outotec’s delivery includes basic design of bauxite silos and engineering and supply of two ball mills with a capacity of 434 tph each,

Magnus Grönborg, new CEO for OXE Marine AB

Magnus Grönborg has today (1 July 2021) assumed the CEO position for OXE Marine AB (publ) (NASDAQ STO: OXE), (OTCQX: CMMCF).Magnus Grönborg succeeds Myron Mahendra who will assume the position of EVP Business Development, Sales and Marketing. Appointing Magnus Grönborg is part of the previously communicated move into the next phase of OXE Marine´s development, with third party production facilities in both Poland and the US, where the board of directors has resolved to reorganize the management team to optimize the Company’s ability to achieve its financial and operational targets.   “

Invitation to Epiroc’s results presentation for Q2 2021 on July 20

Stockholm, Sweden: Epiroc AB, a leading productivity and sustainability partner for the mining and infrastructure industries, will publish its Q2 2021 results on Tuesday July 20 at approximately 11.30 CEST. A results presentation for investors, analysts and media will be held at 13.00 CEST.The report will be presented by President and CEO Helena Hedblom and CFO Anders Lindén. It will be held in English and begin with a short presentation of the report followed by a question-and-answer session. To join the presentation, either access the link here 

Mandatum Asset Management acquires Trevian’s fund business

Mandatum Asset Management has signed an agreement concerning the purchase of real estate fund management company Trevian Funds AIFM Ltd. In connection with the transaction, Trevian’s entire fund management business, including the personnel employed by the company, will transfer to Mandatum Asset Management.Trevian Funds AIFM is a Finnish privately owned real estate fund management company that currently manages two funds: Trevian Finland Properties I and Trevian Carbon Sink Real Estate I Ky. Established in 2017, Trevian Funds AIFM has more than EUR 300 million in assets under management.

Stora Enso completes co-determination negotiations at Kvarnsveden site concerning the closure of pulp and paper production

STORA ENSO OYJ INVESTOR NEWS 1 July 2021 at 09:30 EESTStora Enso has completed the co-determination negotiations concerning the closing down the pulp and paper production at its Kvarnsveden site in Sweden. The closure will take place by the end of the third quarter of 2021. In April 2021, Stora Enso announced a plan to permanently close down pulp and paper production at its Kvarnsveden site due to the declining paper market. As a result of the co-determination negotiations regarding the Kvarnsveden site, pulp and paper production will be closed permanently by the end of the third quarter

Valmet has completed the acquisitions of EWK Umwelttechnik and ECP Group to strengthen its environmental systems business

Valmet Oyj’s press release on July 1, 2021 at 9:30 a.m. EETValmet has completed the acquisition of EWK Umwelttechnik GmbH and ECP Group Oy following the agreements that were announced on June 10. EWK Umwelttechnik is a German company manufacturing and supplying air emission control systems and after-installation services. ECP Group is a manufacturer and maintainer of electrostatic precipitators (ESP), focusing on power plants and pulp and paper industry, in Finland. EWK Umwelttechnik and ECP Group will be included in Valmet’s financial reporting for the first time in Valmet’s third

Nightingale Health quarterly summary of achieved key milestones and reiteration of near-term business targets

Company Release1 July 2021 at 9:25 a.m. (Finnish time)After the commencement of trading ofin its series B shares on Nasdaq First North Growth Market in March 2021, Nightingale Health Oyj (“Nightingale”) has completed the following milestones during the quarter started in April 2021 and ended in June 2021: · In April 2021, Nightingale’s fully owned subsidiary received clinical laboratory certification in Japan. Receiving the clinical laboratory certification prepared Nightingale for commercial launch of its service in Japan. · In April 2021, Nightingale entered into a strategic

Gaming Innovation Group signs Pennsylvania platform agreement with partner PlayStar

Gaming Innovation Group Inc. (GiG) has signed a long-term agreement with current partner PlayStar Casino, for the provision of GiG’s iGaming platform technologies to power the brand’s expansion into the state of Pennsylvania. Building on the foundation of the initial partnership, PlayStar Casino will use GiG to power its casino's second US market entry. This second agreement between GiG and PlayStar Casino is based on a revenue share model and has a minimum duration of four years. PlayStar Casino is a privately owned company founded and operated by industry pioneer Joel Wikell (founder

XNK Therapeutics Reports First Patient Included in Phase II Study in Multiple Myeloma

July 1, 2021 XNK Therapeutics AB (“XNK”) today announced that the first patient has been included in a Phase II clinical study to treat patients with Multiple myeloma using XNK’s leading autologous natural killer (NK) cell-based candidate drug in combination with Sanofi’s anti-CD38 antibody Sarclisa (Isatuximab).“Having the first patient included in this clinical study is a key step in XNK’s development”, said Johan Liwing, CEO of XNK Therapeutics. “While our leading drug candidate is now entering into Phase II, we are in parallel dedicated to progressing our clinical development plan

Basware publishes Half Year Financial Report for January–June 2021 on Thursday, July 15, 2021

Basware Corporation, press release, July 1, 2021 at 9.00 a.m. EESTBasware Corporation publishes Half Year Financial Report for January 1–June 30, 2021 on Thursday, July 15, 2021 at 8.45 a.m. EEST. The report and presentation material will be available on the company’s investor website at investors.basware.com/en after publishing. Basware arranges a briefing for analysts and press, where CEO Klaus Andersen and CFO Martti Nurminen will comment on the events and financial performance of the past quarter. The results briefing can be followed via live webcast or teleconference. A recording of

There are no items matching the current filter
There are no more items matching the current filter
Back to top